AZD 2914
Alternative Names: AZD2914Latest Information Update: 28 Jun 2006
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 08 Jun 2006 Discontinued - Preclinical for Chronic obstructive pulmonary disease in United Kingdom (unspecified route)
- 27 Jan 2005 Preclinical trials in Chronic obstructive pulmonary disease in United Kingdom (unspecified route)